Viewing Study NCT02523495


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-02-23 @ 8:08 PM
Study NCT ID: NCT02523495
Status: UNKNOWN
Last Update Posted: 2018-08-07
First Post: 2015-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
Sponsor: Huazhong University of Science and Technology
Organization:

Study Overview

Official Title: None
Status: UNKNOWN
Status Verified Date: 2018-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer and explore some biomarkers that relate to target therapy.
Detailed Description: 1. Establish a clinical database of patients who are diagnosed with metastasis colorectal cancer in tongji hospital.
2. Build a biological specimen banks of metastasis colorectal cancer through collecting blood samples from those patients who have reached an agreement with us.
3. Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer.
4. To extract DNA from the blood and explore some biomarkers that related to target therapy in metastasis colorectal cancer.

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: